4//SEC Filing
Wooldridge James 4
Accession 0001140361-18-009668
CIK 0001636282other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 6:25 PM ET
Size
5.5 KB
Accession
0001140361-18-009668
Insider Transaction Report
Form 4
Wooldridge James
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2018-02-20+45,000→ 45,000 totalExercise: $6.31Exp: 2028-02-19→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 20, 2018, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
Documents
Issuer
Aeglea BioTherapeutics, Inc.
CIK 0001636282
Entity typeother
Related Parties
1- filerCIK 0001710641
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 6:25 PM ET
- Size
- 5.5 KB